Earnings History Data for DiaMedica Therapeutics Inc. (DMAC) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
DiaMedica Therapeutics Inc.
DiaMedica Therapeutics Inc. is a biopharmaceutical company. It engages in the development of novel recombinant proteins and monoclonal antibodies. The companys lead product principally consists DM199, a recombinant human tissue kallikrein-1 protein. It operates primarily in the United States and Canada. DiaMedica Therapeutics Inc. is headquartered in Minneapolis, Minnesota.
| Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 08-05-2024 | AH | DMAC | DiaMedica Therapeutics Inc. | 132.85 | -0.14 | -0.16 | -0.20 | DiaMedica Therapeutics GAAP EPS of -$0.14 beats by $0.02 [5/8/2024 4:49 PM] |
3.26 | -0.21 (-6.05%) |
3.43 | -0.04 (-1.15%) |
1.58 - 4.75 | 67,136 | 60,000 | 604 | ||
| 19-03-2024 | AH | DMAC | DiaMedica Therapeutics | 115.00 | -0.14 | -0.14 | 0.00 | DiaMedica Therapeutics GAAP EPS of -$0.60 in-line [3/19/2024 4:31 PM] |
2.78 | -0.04 (-1.26%) |
2.84 | 0.02 (0.71%) |
1.46 - 4.75 | 71,345 | 30,000 | 571 | ||
| 13-11-2023 | AH | DMAC | DiaMedica Therapeutics Inc. | 89.18 | -0.12 | -0.14 | -0.12 | DiaMedica Therapeutics GAAP EPS of -$0.12 beats by $0.01 [11/13/2023 4:38 PM] |
2.50 | 0.16 (6.84%) |
0.0 | 0.0 (0.00%) |
1.12 - 4.75 | 131,160 | 50,000 | 0 | ||
| 14-08-2023 | AH | DMAC | DiaMedica Therapeutics Inc. | 75.15 | -0.16 | -0.22 | -0.13 | DiaMedica Therapeutics GAAP EPS of -$0.16 beats by $0.02 [8/14/2023 4:23 PM] |
2.96 | 0.12 (4.23%) |
2.93 | 0.09 (3.17%) |
1.12 - 4.75 | 128,037 | 100,000 | 540 | ||
| 15-05-2023 | AH | 4:15 PM ET (May 15) |
DMAC | DiaMedica Therapeutics Inc. | 42.87 | -0.20 | -0.16 | -0.13 | DiaMedica Therapeutics reports Q1 results [5/15/2023 4:54 PM] |
1.75 | -0.24 (-11.97%) |
1.98 | -0.01 (-0.40%) |
1.12 - 2.53 | 77,292 | 40,000 | 1,847 | |
| 28-03-2023 | AH | 4:15 PM ET (Mar 28) |
DMAC | DiaMedica Therapeutics Inc. | 47.07 | -0.14 | -0.14 | -0.10 | DiaMedica Therapeutics GAAP EPS of -$0.52 in-line [3/28/2023 4:32 PM] |
1.49 | -0.03 (-1.97%) |
0.0 | 0.0 (0.00%) |
1.12 - 2.71 | 37,475 | 20,000 | 0 | |
| 10-08-2022 | AH | 4:30 PM ET (Aug 10) |
DMAC | DiaMedica Therapeutics Inc. | 40.46 | -0.13 | -0.16 | -0.17 | DiaMedica Therapeutics GAAP EPS of -$0.13 beats by $0.05 [8/10/2022 5:30 PM] |
1.89 | 0.16 (9.25%) |
1.74 | 0.01 (0.58%) |
1.15 - 4.82 | 65,356 | 50,000 | 2,048 | |
| 04-05-2022 | AH | 4:45 PM ET (May 4) |
DMAC | DiaMedica Therapeutics | 61.00 | -0.13 | -0.20 | 0.00 | DiaMedica Therapeutics GAAP EPS of -$0.13 beats by $0.07 [5/4/2022 5:22 PM] |
2.31 | -0.17 (-6.85%) |
2.58 | -0.04 (-1.53%) |
2.12 - 9.64 | 24,926 | 50,000 | 385 | |
| 14-03-2022 | AH | 4:35 PM ET (Mar 14) |
DMAC | DiaMedica Therapeutics Inc. | 69.01 | -0.10 | -0.16 | -0.23 | DiaMedica Therapeutics GAAP EPS of -$0.65 beats by $0.08 [3/14/2022 4:48 PM] |
2.33 | 0.02 (0.87%) |
0.0 | 0.0 (0.00%) |
2.20 - 10.71 | 25,353 | 30,000 | 0 | |
| 10-11-2021 | AH | 4:30 PM ET (Nov 10) |
DMAC | DiaMedica Therapeutics Inc. | 87.14 | -0.18 | -0.23 | -0.19 | DiaMedica Therapeutics EPS beats by $0.05 [11/10/2021 4:44 PM] |
4.50 | 0.04 (0.90%) |
4.40 | -0.06 (-1.35%) |
3.00 - 10.88 | 151,709 | 280,000 | 1,081 | |
|
||||||||||||||||||
| 11-08-2021 | AH | 4:30 PM ET (Aug 11) |
DMAC | DiaMedica Therapeutics Inc. | 63.71 | -0.17 | -0.19 | -0.17 | DiaMedica Therapeutics EPS beats by $0.05 [8/11/2021 4:54 PM] |
3.22 | -0.16 (-4.73%) |
3.52 | 0.14 (4.14%) |
3.16 - 10.88 | 143,307 | 110,000 | 26,438 | |
| 05-05-2021 | AH | 4:00 PM ET (May 5) |
DMAC | DiaMedica Therapeutics Inc. | 176.15 | -0.19 | -0.23 | -0.19 | DiaMedica Therapeutics reports Q1 results [5/5/2021 4:37 PM] |
8.57 | -0.87 (-9.22%) |
9.80 | 0.36 (3.81%) |
3.24 - 10.88 | 183,116 | 60,000 | 1,233 | |
| 10-03-2021 | AH | 4:30 PM ET (Mar 10) |
DMAC | DiaMedica Therapeutics Inc. | 153.29 | -0.23 | -0.18 | -0.21 | DiaMedica Therapeutics EPS misses by $0.06 [3/10/2021 4:35 PM] |
9.15 | 0.34 (3.86%) |
8.90 | 0.09 (1.02%) |
1.87 - 10.88 | 137,366 | 134,975 | 500 | |
|
||||||||||||||||||
| 04-11-2020 | AH | 4:05 PM ET (Nov 4) |
DMAC | DiaMedica Therapeutics Inc. | 82.45 | -0.19 | 0.00 | -0.20 | DiaMedica Therapeutics EPS misses by $0.04 [11/4/2020 5:11 PM] |
4.50 | -0.08 (-1.75%) |
0.0 | 0.0 (0.00%) |
1.87 - 8.80 | 3,925 | 62,034 | 0 | |
|
|
||||||||||||||||||
| 11-08-2020 | AH | 4:40 PM ET (Aug 11) |
DMAC | DiaMedica Therapeutics Inc. | 77.06 | -0.17 | 0.00 | -0.21 | DiaMedica Therapeutics EPS misses by $0.02 [8/11/2020 4:30 PM] |
5.30 | -0.10 (-1.85%) |
5.50 | 0.10 (1.85%) |
1.70 - 8.80 | 44,228 | 138,365 | 1,395 | |
|
|
||||||||||||||||||
| 13-05-2020 | AH | 4:35 PM ET (May 13) |
DMAC | DiaMedica Therapeutics Inc. | 54.01 | -0.19 | -0.28 | -0.27 | DiaMedica Therapeutics EPS beats by $0.09 [5/13/2020 4:44 PM] |
4.50 | 0.66 (17.19%) |
4.74 | 0.90 (23.44%) |
1.70 - 5.93 | 618,831 | 53,493 | 18,053 | |
|
|
||||||||||||||||||